Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 3
2019 2
2020 1
2021 4
2022 6
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244.
Horspool AM, Sen-Kilic E, Malkowski AC, Breslow SL, Mateu-Borras M, Hudson MS, Nunley MA, Elliott S, Ray K, Snyder GA, Miller SJ, Kang J, Blackwood CB, Weaver KL, Witt WT, Huckaby AB, Pyles GM, Clark T, Al Qatarneh S, Lewis GK, Damron FH, Barbier M. Horspool AM, et al. Among authors: sen kilic e. Front Cell Infect Microbiol. 2023 Apr 14;13:1117844. doi: 10.3389/fcimb.2023.1117844. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37124031 Free PMC article.
Monoclonal antibodies against lipopolysaccharide protect against Pseudomonas aeruginosa challenge in mice.
Kang J, Mateu-Borrás M, Monroe HL, Sen-Kilic E, Miller SJ, Dublin SR, Huckaby AB, Yang E, Pyles GM, Nunley MA, Chapman JA, Amin MS, Damron FH, Barbier M. Kang J, et al. Among authors: sen kilic e. Front Cell Infect Microbiol. 2023 Jun 22;13:1191806. doi: 10.3389/fcimb.2023.1191806. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37424774 Free PMC article.
Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2.
Barbier M, Lee KS, Vikharankar MS, Rajpathak SN, Kadam N, Wong TY, Russ BP, Cyphert HA, Miller OA, Rader NA, Cooper M, Kang J, Sen-Kilic E, Wong ZY, Winters MT, Bevere JR, Martinez I, Devarumath R, Shaligram US, Damron FH. Barbier M, et al. Among authors: sen kilic e. Front Immunol. 2022 Aug 15;13:948431. doi: 10.3389/fimmu.2022.948431. eCollection 2022. Front Immunol. 2022. PMID: 36091051 Free PMC article.
Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge.
Wong TY, Lee KS, Russ BP, Horspool AM, Kang J, Winters MT, Allison Wolf M, Rader NA, Miller OA, Shiflett M, Izac J, Varisco D, Sen-Kilic E, Cunningham C, Cooper M, Cyphert HA, Barbier M, Martinez I, Bevere JR, Ernst RK, Damron FH. Wong TY, et al. Among authors: sen kilic e. NPJ Vaccines. 2022 Mar 14;7(1):36. doi: 10.1038/s41541-022-00451-7. NPJ Vaccines. 2022. PMID: 35288576 Free PMC article.
Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge.
Weaver KL, Bitzer GJ, Wolf MA, Pyles GM, DeJong MA, Dublin SR, Huckaby AB, Gutierrez MP, Hall JM, Wong TY, Warden M, Petty JE, Witt WT, Cunningham C, Sen-Kilic E, Damron FH, Barbier M. Weaver KL, et al. Among authors: sen kilic e. PLoS One. 2023 Nov 2;18(11):e0286925. doi: 10.1371/journal.pone.0286925. eCollection 2023. PLoS One. 2023. PMID: 37917623 Free PMC article.
Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice.
Wolf MA, Boehm DT, DeJong MA, Wong TY, Sen-Kilic E, Hall JM, Blackwood CB, Weaver KL, Kelly CO, Kisamore CA, Bitzer GJ, Bevere JR, Barbier M, Damron FH. Wolf MA, et al. Among authors: sen kilic e. Infect Immun. 2021 Feb 16;89(3):e00607-20. doi: 10.1128/IAI.00607-20. Print 2021 Feb 16. Infect Immun. 2021. PMID: 33318136 Free PMC article.
23 results